Daniel M. Geynisman, MD

Daniel M. Geynisman, MD, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Center

Articles by Daniel M. Geynisman, MD

Daniel M. Geynisman, MDMuscle Invasive Urothelial Carcinoma | February 4, 2025

Dr. Geynisman shares insights on the feasibility of bladder-sparing approaches in treating muscle-invasive bladder cancer.

Daniel M. Geynisman, MDMuscle Invasive Urothelial Carcinoma | January 10, 2025

Dr. Geynisman reviews the RETAIN 1 trial evaluating whether certain patients with MIBC can safely avoid invasive procedures.

Daniel M. Geynisman, MDASCO GU Symposium 2024 | January 30, 2024

Dr. Geynisman highlights the CheckMate 274 study into long-term survival following treatment with adjuvant nivolumab.

Daniel M. Geynisman, MDASCO GU Symposium 2023 | February 24, 2023

Daniel M. Geynisman, MD, explains the results and utility of the RETAIN trial for bladder sparing in patients with MIBC.